Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۲۸ • واحد: joints
حداقل ۰ — حداکثر ۲۸ • واحد: joints
حداقل ۱ — حداکثر ۲۰۰ • واحد: mm/hr
حداقل ۰ — حداکثر ۱۰ • واحد: scale
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Remission0–2.6
- Low2.6–3.2
- Moderate3.2–5.1
- High5.1–10
The Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR) calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include tender joint count. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically ESR
Clinical Indication
The Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR) is indicated for bedside clinical practice to support Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically ESR. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.
Limitations & Contraindications
Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.
Clinical Pearls & Action Plan
Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology.
DAS28-ESR = 0.56*√(tender joint count) + 0.28*√(swollen joint count) + 0.70*ln(ESR) + 0.014*patient global health*10
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| tender_joint_count | integer | Yes | Number of tender joints (0-28)(joints) |
| swollen_joint_count | integer | Yes | Number of swollen joints (0-28)(joints) |
| esr_level | integer | Yes | Erythrocyte sedimentation rate in mm/hr(mm/hr) |
| patient_global_health | integer | Yes | Patient's global assessment of disease activity (0-10 scale, where 0 = very well, 10 = very poor)(scale) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2.6 | Remission | Disease remission |
| 2.6–3.2 | Low | Low disease activity |
| 3.2–5.1 | Moderate | Moderate disease activity |
| 5.1–10 | High | High disease activity |
Evidence-Based References (EBM)
- van der Heijde DM, van 't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990 Nov;49(11):916-20. doi: 10.1136/ard.49.11.916.DOI: 10.1136/ard.49.11.916
- Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995 Jan;38(1):44-8. doi: 10.1002/art.1780380107.DOI: 10.1002/art.1780380107
- Tamhane A, Redden DT, McGwin G Jr, Brown EE, Westfall AO, Reynolds RJ, Callahan L, Conn DL, Jonas BL, Smith RP, Brasington RD Jr, Moreland LW, Bridges SL Jr. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol. 2013 Nov;40(11):1812-22. doi: 10.3899/jrheum.121225.DOI: 10.3899/jrheum.121225